| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.0011 | 1 |